These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Emancipating Chlamydia: Advances in the Genetic Manipulation of a Recalcitrant Intracellular Pathogen. Bastidas RJ; Valdivia RH Microbiol Mol Biol Rev; 2016 Jun; 80(2):411-27. PubMed ID: 27030552 [TBL] [Abstract][Full Text] [Related]
3. Considerations on Chlamydia trachomatis disease expression. Brunham RC; Rekart ML FEMS Immunol Med Microbiol; 2009 Mar; 55(2):162-6. PubMed ID: 19159424 [TBL] [Abstract][Full Text] [Related]
4. Chlamydia trachomatis ChxR is a transcriptional regulator of virulence factors that function in in vivo host-pathogen interactions. Yang C; Kari L; Sturdevant GL; Song L; Patton MJ; Couch CE; Ilgenfritz JM; Southern TR; Whitmire WM; Briones M; Bonner C; Grant C; Hu P; McClarty G; Caldwell HD Pathog Dis; 2017 Apr; 75(3):. PubMed ID: 28369275 [TBL] [Abstract][Full Text] [Related]
6. Chlamydia trachomatis and its interaction with the cellular retromer. Banhart S; Rose L; Aeberhard L; Koch-Edelmann S; Heuer D Int J Med Microbiol; 2018 Jan; 308(1):197-205. PubMed ID: 29122514 [TBL] [Abstract][Full Text] [Related]
7. Markerless Gene Deletion by Floxed Cassette Allelic Exchange Mutagenesis in Chlamydia trachomatis. Keb G; Fields KA J Vis Exp; 2020 Jan; (155):. PubMed ID: 32065159 [TBL] [Abstract][Full Text] [Related]
8. Potential protective effect of a G>A SNP in the 3'UTR of HLA-A for Chlamydia trachomatis symptomatology and severity of infection. Jansen ME; Branković I; Spaargaren J; Ouburg S; Morré SA Pathog Dis; 2016 Mar; 74(2):. PubMed ID: 26656886 [TBL] [Abstract][Full Text] [Related]
9. Drosophila melanogaster S2 cells: a model system to study Chlamydia interaction with host cells. Elwell C; Engel JN Cell Microbiol; 2005 May; 7(5):725-39. PubMed ID: 15839901 [TBL] [Abstract][Full Text] [Related]
12. Male genital tract immune response against Mackern-Oberti JP; Motrich RD; Damiani MT; Saka HA; Quintero CA; Sánchez LR; Moreno-Sosa T; Olivera C; Cuffini C; Rivero VE Reproduction; 2017 Oct; 154(4):R99-R110. PubMed ID: 28878094 [No Abstract] [Full Text] [Related]
13. Development of a Chlamydia trachomatis vaccine for urogenital infections: novel tools and new strategies point to bright future prospects. Hafner LM; Timms P Expert Rev Vaccines; 2018 Jan; 17(1):57-69. PubMed ID: 29264970 [TBL] [Abstract][Full Text] [Related]
14. Floxed-Cassette Allelic Exchange Mutagenesis Enables Markerless Gene Deletion in Chlamydia trachomatis and Can Reverse Cassette-Induced Polar Effects. Keb G; Hayman R; Fields KA J Bacteriol; 2018 Dec; 200(24):. PubMed ID: 30224436 [TBL] [Abstract][Full Text] [Related]
15. Impact of host genetics on susceptibility to human Chlamydia trachomatis disease. Mahdi OS Br J Biomed Sci; 2002; 59(2):128-32. PubMed ID: 12113404 [TBL] [Abstract][Full Text] [Related]
16. The mucosal immune response to Chlamydia trachomatis infection of the reproductive tract in women. Agrawal T; Vats V; Salhan S; Mittal A J Reprod Immunol; 2009 Dec; 83(1-2):173-8. PubMed ID: 19896206 [TBL] [Abstract][Full Text] [Related]
17. Chlamydia trachomatis Is Responsible for Lipid Vacuolation in the Amniotic Epithelium of Fetal Gastroschisis. Feldkamp ML; Ward DM; Pysher TJ; Chambers CT Birth Defects Res; 2017 Jul; 109(13):1003-1010. PubMed ID: 28635162 [TBL] [Abstract][Full Text] [Related]
18. Host genetic contribution to the cellular immune response to Chlamydia trachomatis: Heritability estimate from a Gambian twin study. Bailey RL; Natividad-Sancho A; Fowler A; Peeling RW; Mabey DC; Whittle HC; Jepson AP Drugs Today (Barc); 2009 Nov; 45 Suppl B():45-50. PubMed ID: 20011694 [TBL] [Abstract][Full Text] [Related]